Atlas Venture Opportunity Fund II, Shareholder: Dyne Therapeutics DYN Planned sale · Filed 06/23

Trade details

Type: Planned sale notice
Stock: Dyne Therapeutics DYN
Person: Atlas Venture Opportunity Fund IIShareholder
Planned sale date: 26/06/23
Filed: 26/06/23

$816.7K to be sold

Dyne Therapeutics trades, last 26 weeks

What else happened in Dyne Therapeutics around then

Filed or reported within 30 days of the trade day · 05/24~07/23

Atlas Venture Opportunity Fund II's recent trades

Atlas Venture Opportunity Fund IIShareholder
Planned sale10b5-1 planKorro Bio
Planned sale10b5-1 plan
Korro Bio
KRRO
$91.2K
6,602 sh
$91.2K
Filed 09/14
Traded 09/14
Atlas Venture Opportunity Fund IIShareholder
Planned sale10b5-1 planKorro Bio
Planned sale10b5-1 plan
Korro Bio
KRRO
$22.9K
1,750 sh
$22.9K
Filed 09/11
Traded 09/11
Atlas Venture Opportunity Fund IIShareholder
Planned saleDisc Medicine
Planned sale
Disc Medicine
IRON
$60.2K
759 sh
$60.2K
Filed 09/04
Traded 09/04
Atlas Venture Opportunity Fund IIShareholder
Planned saleDisc Medicine
Planned sale
Disc Medicine
IRON
$187.2K
2,339 sh
$187.2K
Filed 09/03
Traded 09/03
Atlas Venture Opportunity Fund IIShareholder
Planned saleDisc Medicine
Planned sale
Disc Medicine
IRON
$1.7M
22,099 sh
$1.7M
Filed 09/02
Traded 09/02